Dr. Reddy’s Q1 net profit at Rs 1,392 crore, exceeds expectations; revenue grows 14%
Dr. Reddy's Laboratories reported a net profit of Rs 1,392 crore for Q1 FY25, surpassing expectations. Revenue grew by 14 percent to Rs 7,672.70 crore, driven by strong generics sales in North America and India. Despite a slight decline in EBITDA margin, the results highlight the company's growth potential and resilience.